Clinical trial
Prospective Non-interventional Study to Investigate the Relationship Between Duration of Treatment (DoT) and Response in Patients With Multiple Myeloma or Systemic AL Amyloidosis Treated in Real-life Clinical Practice
NCT04659798 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Non-interventional Study to Investigate the Relationship Between Duration of Treatment (DoT) and Response in Patients With Multiple Myeloma or Systemic AL Amyloidosis Treated in Real-life Clinical Practice
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 22, 2021
- Completion date
- September 5, 2023
- Enrollment
- 240 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.